aurintricarboxylic acid has been researched along with cyclic gmp in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nicklas, WJ; Schoepp, D; Zeevalk, GD | 1 |
Farinelli, SE; Greene, LA; Park, DS; Stefanis, L; Yan, CY | 1 |
Fridkin, M; Gozes, I; Granoth, R; Rubinraut, S | 1 |
3 other study(ies) available for aurintricarboxylic acid and cyclic gmp
Article | Year |
---|---|
Aurintricarboxylic acid prevents NMDA-mediated excitotoxicity: evidence for its action as an NMDA receptor antagonist.
Topics: Animals; Aurintricarboxylic Acid; Chick Embryo; Cyclic GMP; GABA Antagonists; gamma-Aminobutyric Acid; N-Methylaspartate; Neurotoxins; Receptors, N-Methyl-D-Aspartate; Time Factors | 1993 |
Ordering the cell death pathway. Differential effects of BCL2, an interleukin-1-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells.
Topics: Acetylcysteine; Animals; Apoptosis; Apoptosis Regulatory Proteins; Aurintricarboxylic Acid; Calcium-Calmodulin-Dependent Protein Kinases; Carrier Proteins; Caspase 1; Cells, Cultured; Cyclic AMP; Cyclic GMP; Cysteine Endopeptidases; Dactinomycin; Deferoxamine; Enzyme Activation; Humans; In Vitro Techniques; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Nerve Growth Factors; PC12 Cells; Rats; RNA; Serpins; Viral Proteins | 1996 |
VIP-derived sequences modified by N-terminal stearyl moiety induce cell death: the human keratinocyte as a model.
Topics: Apoptosis; Aurintricarboxylic Acid; Cell Death; Cell Division; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Keratinocytes; L-Lactate Dehydrogenase; Microscopy, Phase-Contrast; Vasoactive Intestinal Peptide | 2000 |